S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
66,000% upside on tiny biotech? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
66,000% upside on tiny biotech? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Laser breakthrough could send stock soaring 2,467% (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
66,000% upside on tiny biotech? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
66,000% upside on tiny biotech? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Laser breakthrough could send stock soaring 2,467% (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
66,000% upside on tiny biotech? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
66,000% upside on tiny biotech? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Laser breakthrough could send stock soaring 2,467% (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
66,000% upside on tiny biotech? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
66,000% upside on tiny biotech? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Laser breakthrough could send stock soaring 2,467% (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NASDAQ:AHPAU

Avista Healthcare Public Acquisition Corp. Units (AHPAU) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$6.16
$7.78
50-Day Range
N/A
52-Week Range
$10.00
$10.45
Volume
2,637 shs
Average Volume
3,829 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AHPAU vs. SVNAW, ASCBW, AVHIW, GMFIW, AHRNW, AIBBU, AIMAU, ALSAW, ACAXW, and ALORW

Should you be buying Avista Healthcare Public Acquisition Corp. Units stock or one of its competitors? The main competitors of Avista Healthcare Public Acquisition Corp. Units include 7 Acquisition (SVNAW), A SPAC II Acquisition (ASCBW), Achari Ventures Holdings Corp. I (AVHIW), Aetherium Acquisition (GMFIW), Ahren Acquisition (AHRNW), AIB Acquisition (AIBBU), Aimfinity Investment Corp. I (AIMAU), Alpha Star Acquisition (ALSAW), Alset Capital Acquisition (ACAXW), and ALSP Orchid Acquisition Co. I (ALORW). These companies are all part of the "shell companies" industry.

Avista Healthcare Public Acquisition Corp. Units vs.

Avista Healthcare Public Acquisition Corp. Units (NASDAQ:AHPAU) and 7 Acquisition (NASDAQ:SVNAW) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, community ranking, valuation, earnings, risk and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avista Healthcare Public Acquisition Corp. Units
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
7 Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avista Healthcare Public Acquisition Corp. UnitsN/AN/AN/AN/AN/A
7 AcquisitionN/AN/AN/AN/AN/A

Avista Healthcare Public Acquisition Corp. Units received 34 more outperform votes than 7 Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Avista Healthcare Public Acquisition Corp. UnitsOutperform Votes
34
64.15%
Underperform Votes
19
35.85%
7 AcquisitionN/AN/A

Company Net Margins Return on Equity Return on Assets
Avista Healthcare Public Acquisition Corp. Units N/A N/A N/A
7 Acquisition N/A N/A N/A

In the previous week, Avista Healthcare Public Acquisition Corp. Units' average media sentiment score of 0.00 equaled 7 Acquisition's average media sentiment score.

Company Overall Sentiment
Avista Healthcare Public Acquisition Corp. Units Neutral
7 Acquisition Neutral

Summary

Avista Healthcare Public Acquisition Corp. Units beats 7 Acquisition on 1 of the 1 factors compared between the two stocks.


Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AHPAU vs. The Competition

MetricAvista Healthcare Public Acquisition Corp. UnitsShell Companies IndustryFinance SectorNASDAQ Exchange
Market CapN/A$60.87M$6.14B$6.29B
Dividend YieldN/AN/A10.05%6.49%
P/E RatioN/A0.38157.5913.66
Price / SalesN/A1,841.396,531.9796.13
Price / CashN/A92.8332.8276.28
Price / BookN/A1.841.865.39
Net IncomeN/A-$2.06M$649.38M$192.60M

Avista Healthcare Public Acquisition Corp. Units Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVNAW
7 Acquisition
0 of 5 stars
$0.00
-28.6%
N/A-99.5%$0.00N/A0.00N/AGap Down
ASCBW
A SPAC II Acquisition
0 of 5 stars
$0.03
flat
N/AN/A$0.00N/A0.00N/A
AVHIW
Achari Ventures Holdings Corp. I
0 of 5 stars
$0.01
flat
N/AN/A$0.00N/A0.00N/A
GMFIW
Aetherium Acquisition
0 of 5 stars
$0.02
-33.2%
N/A-79.9%$0.00N/A0.00N/AGap Down
AHRNW
Ahren Acquisition
0 of 5 stars
$0.03
flat
N/AN/A$0.00N/A0.00N/A
AIBBU
AIB Acquisition
0 of 5 stars
$10.91
flat
N/AN/A$0.00N/A0.00N/A
AIMAU
Aimfinity Investment Corp. I
0 of 5 stars
$10.58
flat
N/AN/A$0.00N/A0.00N/A
ALSAW
Alpha Star Acquisition
0 of 5 stars
$0.01
flat
N/A-76.7%$0.00N/A0.00N/AGap Down
ACAXW
Alset Capital Acquisition
0 of 5 stars
$0.03
flat
N/A-62.5%$0.00N/A0.00N/A
ALORW
ALSP Orchid Acquisition Co. I
0 of 5 stars
$0.03
flat
N/A-44.1%$0.00N/A0.00N/AGap Up

Related Companies and Tools

This page (NASDAQ:AHPAU) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -